Cargando…
Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
BACKGROUND: The antiproliferative activity of octreotide LAR in neuroendocrine tumours (NETs) has been demonstrated by small retrospective studies and confirmed by a prospective phase III trial (PROMID). However, there are limited data about the duration and predictors of response. The aim of our re...
Autores principales: | Laskaratos, Faidon-Marios, Walker, Martin, Naik, Keval, Maragkoudakis, Emmanouil, Oikonomopoulos, Nikolaos, Grant, Lee, Meyer, Tim, Caplin, Martyn, Toumpanakis, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129835/ https://www.ncbi.nlm.nih.gov/pubmed/27811856 http://dx.doi.org/10.1038/bjc.2016.349 |
Ejemplares similares
-
What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
por: Ratnayake, Gowri M., et al.
Publicado: (2022) -
Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2020) -
Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019) -
Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019) -
Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)